J K Shepherd
Overview
Explore the profile of J K Shepherd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
511
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hendrie C, Neill J, Shepherd J, Dourish C
Physiol Behav
. 1993 Oct;
54(4):689-93.
PMID: 7902586
In view of evidence suggesting that cholecystokinin (CCK) may have a role in the mediation of human panic disorders, it was predicted that CCK receptor antagonists may have anxiolytic-like activity...
12.
Blanchard R, Shepherd J, Armstrong J, Tsuda S, Blanchard D
Psychopharmacology (Berl)
. 1993 Jan;
112(1):55-63.
PMID: 7871010
Several behaviors associated with the serotonin syndrome have been reported in rats following administration of the 5-HT1A receptor agonist 8-OH-DPAT. The present investigation approached this phenomenon from an ethopharmacological perspective,...
13.
Blanchard R, Shepherd J, Rodgers R, Magee L, Blanchard D
Psychopharmacology (Berl)
. 1993 Jan;
110(1-2):245-53.
PMID: 7870893
The anxiety/defense test battery has been developed to assess defensive reactions in rats to situations associated with a natural predator, the domestic cat. This comprises three paradigms designed to study...
14.
Rodgers R, Shepherd J
Psychopharmacology (Berl)
. 1993 Jan;
113(2):237-42.
PMID: 7855188
A single prior undrugged exposure to the elevated plus-maze has been reported to reduce open arm activity on retest and to attenuate/abolish the anxiolytic response to benzodiazepines at retest intervals...
15.
Rodgers R, Shepherd J
Neuropharmacology
. 1992 Jun;
31(6):553-60.
PMID: 1407395
Recent studies have shown that non-opioid defensive analgesia in male mice is potently inhibited by the 5-HT3 receptor antagonist, ondansetron. The present series of experiments was conducted to further explore...
16.
Shepherd J, Blanchard D, Weiss S, Rodgers R, Blanchard R
Pharmacol Biochem Behav
. 1992 Mar;
41(3):551-8.
PMID: 1584834
Mixed-sex groups of laboratory rats living in a visible burrow system (VBS) emit 18-27 kHz ultrasound and retreat to the burrow when a cat is placed in the open area...
17.
Shepherd J, Flores T, Rodgers R, Blanchard R, Blanchard D
Physiol Behav
. 1992 Feb;
51(2):277-85.
PMID: 1557438
The anxiety/defense test battery has been developed to measure defensive reactions in laboratory rats to both direct exposure to, and stimuli associated with, a natural predator, the domestic cat. The...
18.
Rodgers R, Lee C, Shepherd J
Psychopharmacology (Berl)
. 1992 Jan;
106(1):102-10.
PMID: 1738787
Recent studies have shown that brief exposure to an elevated plus-maze (EPM) produces non-opioid antinociception in male mice. The present experiments were designed to assess the effects of diazepam on...
19.
Blanchard D, Shepherd J, Rodgers R, Blanchard R
Psychopharmacology (Berl)
. 1992 Jan;
106(4):531-9.
PMID: 1533722
The Proxemics/Activity test and the Eat/Drink test, two components of the Anxiety/Defense Test Battery, were developed to measure defensive reactions to situations associated with a natural predator (cat). In the...
20.
Blanchard D, Blanchard R, Carobrez A, Veniegas R, Rodgers R, Shepherd J
Psychopharmacology (Berl)
. 1992 Jan;
108(3):352-62.
PMID: 1523285
The present study investigated the effects of the non-competitive NMDA antagonist MK-801 (0.04-0.16 mg/kg), on antipredator defensive reactions of male and female rats in three paradigms comprising the Anxiety/Defense Test...